Amgen Inc. (AMGN)

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Amgen Inc. (“Amgen ” or “the Company”) (NASDAQ: AMGN). Investors who purchased Amgen securities prior to July 29, 2020, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation.

Investigation Details: 

The investigation concerns whether Amgen and certain of its officers and/or directors have engaged in corporate wrongdoing. 

What’s Next? 

If you are aware of any facts relating to this investigation or purchased Amgen  shares, you can assist this investigation. You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660. 

Why Bronstein, Gewirtz & Grossman: 

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. 

Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 | [email protected]